This Guide to the TRIPS Agreement has been prepared as a background resource for the WTO's technichal assistance on TRIPS. Information is available on the following topics:

Appendices 1 and 2 serve as a guide to TRIPS notifications and related documents. The Annexes contain the full text of the TRIPS Agreement, together with the provisions of the WIPO Conventions, namely, the Paris, Berne, and Rome Conventions, as well as the IPIC Treaty, that have been incorporated into the TRIPS Agreement. The  Annexes also contain the relevant declarations and legal instruments that were adopted subsequent to the TRIPS Agreement coming into effect.

• Appendix 1 — Guide to Transparency Under TRIPS
• Appendix 2 — Guide to TRIPS Documents
• Annex 1 — Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) (as amended on 23 January 2017)
• Annex 2 — Provisions of the Paris Convention for the Protection of Industrial Property (1967) Referred to in the TRIPS Agreement
• Annex 3 — Provisions of the Berne Convention for the Protection of Literary and Artistic Works (1971) Referred to in the TRIPS Agreement
• Annex 4 — Provisions of the International Convention for the Protection of Performers, Producers of Phonograms and Broadcasting Organizations (the Rome Convention) (1961) Referred to in the TRIPS Agreement
• Annex 5 — Provisions of the Treaty on Intellectual Property in Respect of Integrated Circuits (1989) Referred to in the TRIPS Agreement
• Annex 6 — Declaration on the TRIPS Agreement and Public Health
• Annex 7 and Corr.1— Implementation of Paragraph 6 of The Doha Declaration on the TRIPS Agreement and Public Health (Decision of 30 August 2003)
• Annex 8 — Amendment of the TRIPS Agreement (Decision of 6 December 2005)
• Annex 9 — Decision on Extension of the Transition Period under Article 66.1 for Least Developed Country Members (2021)
• Annex 10 — Decision on Extension of the Transition Period under Article 66.1 of the TRIPS Agreement for Least Developed Country Members for Certain Obligations with Respect to Pharmaceutical Products (2015)